BRUSSELS (AP) — The European Union’s executive arm has signed a third vaccine contract with Pfizer and BioNTech through 2023 for an additional 1.8 billion doses of their COVID-19 shots. The European commission said the deal will allow the buying of 900 million doses of the current shots and of a serum adapted to the virus’ variants, with an option to purchase an extra 900 million shots. To avoid delivery delays, the deal with Pfizer-BioNTech stipulates that the production of doses must be based in the EU and that essential components are sourced from the region. Although EU nations agreed to keep on with their strategy of buying doses collectively, Hungary opted out of the new deal Thursday.
The post EU signs new deal with Pfizer-BioNTech, Hungary opts out appeared first on WEEK.